ENTITY
Hansoh Pharmaceutical Group

Hansoh Pharmaceutical Group (3692 HK)

286
Analysis
Health CareChina
Hansoh Pharmaceutical Group Company Limited operates as a pharmaceutical company. The Company manufactures and sells anti-infectives, anti-neoplastic agents, diabetes drugs, and other products. Hansoh Pharmaceutical Group markets its products throughout China.
more
bullishKingsoft Cloud
26 Apr 2020 12:44

ECM Weekly (26 Apr 2020) - Kingsoft Cloud, WeDoctor, Akesobio, Kotak Mahindra Bank

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Akeso...

Share
21 Apr 2020 21:49

Hansoh Pharma Placement - Good Stock but Valuation and No Lack of Cash Makes It Appear Opportunistic

Hansoh Pharmaceutical (3692 HK) aims to raise up to US$450m to funds its R&D and general working capital requirements. The company was listed...

Logo
502 Views
Share
bullishAlibaba
26 Mar 2020 13:37

Trade/Investment Ideas from 2019/20 IPOs

Since the start of 2019 till date, we have covered 96 IPOs. Despite the market turmoil over the past two months, over a third, or 40 IPOs remain...

Logo
659 Views
Share
06 Feb 2020 17:56

HK Connect Flows: What Chinese Buy/Sell on the First Day After Chinese New Year?

In this note, we would take a quick look at the top buys and sells by Chinese investors on the first day of trading over the Hong Kong Connect...

Logo
476 Views
Share
bullishAlibaba
16 Jan 2020 14:57

2019 Hong Kong IPO Analytics: How Did Insti and Retail Coverage Impact Deal Performance

Since the inception of our IPO research in 2015, the Aequitas Research team has covered over 452 IPOs, which raised over US$100m each, across the...

Logo
648 Views
Share
x